Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Peripheral Artery Disease (PAD): early-phase trial registry

4 of 6 indexed Peripheral Artery Disease (PAD) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Peripheral Artery Disease (PAD): 6 US clinical trials tracked, 4 recruiting.

Peripheral Artery Disease (PAD) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is TriReme Medical, running 1 of these trials.

Enrollment posture brief

Registry condition peripheral-artery-disease-pad

OPEN 4 | RECR 67% | LATE 0 | EARLY 1 | RANK #2866 | SPON 1

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Peripheral Artery Diseas (th…67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Peripheral Artery Disease (PAD)

Peripheral Artery Disease (PAD) lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Peripheral Artery Disease (PAD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Peripheral Artery Disease (PAD) is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Peripheral Artery Disease (PAD) research.

    TriReme Medical accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Peripheral Artery Disease (PAD) enrolment sits around 277 participants.

    Median target enrolment is 277 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Peripheral Artery Disease (PAD) splits between interventional and observational designs.

    3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Peripheral Artery Disease (PAD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Care4Today® Connect CAD-PAD Mobile Application Device
1 trials
Lutonix Drug Coated Balloon Device
1 trials
Chocolate Touch Device
1 trials
Segmental pulse arrival time assessment Device
1 trials
Peripheral balloon angioplasty Device
1 trials
GM-CSF Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Peripheral Artery Disease (PAD) trials. A trial with sites in several states counts in each.

Texas 4 trials
Georgia 2 trials
Florida 2 trials
Washington 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
Nebraska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Peripheral Artery Disease (PAD) page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Peripheral Artery Disease (PAD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • TriReme Medical sponsors the most Peripheral Artery Disease (PAD) trials on record, review their full trial history before evaluating a specific study. See TriReme Medical's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Artery Disease (PAD) condition card totals 6 registered trials; most-linked intervention Care4Today® Connect CAD-PAD Mobile Application; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.